Anthony Conway

Anthony Conway is currently the Vice President and Head of Cell Therapy at Replay. Previously, Anthony held various roles at Novo Nordisk and Sangamo Therapeutics, Inc., where Anthony led multiple therapeutic programs focused on gene delivery into different types of stem cells to treat various disorders. Anthony also has experience in investigating bioactive materials to control cell fate and synthesizing materials for drug delivery. Anthony holds a Ph.D. in Chemical and Biomolecular Engineering from the University of California, Berkeley.